Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul-Sep;12(3):221-224.
doi: 10.25122/jml-2019-0053.

Non-Invasive Prenatal Testing beyond Trisomies

Ioan Dumitru Suciu  1   2 , Oana Daniela Toader  2   3 , Slavyana Galeva  4 , Lucian Pop  3
Affiliations
Review

Non-Invasive Prenatal Testing beyond Trisomies

Ioan Dumitru Suciu et al. J Med Life. 2019 Jul-Sep.

Abstract

The last decade has seen incredible advances in the genetic era, in next-generation sequencing of cell-free DNA in the maternal plasma, detecting abnormal fetal chromosomes. Non-invasive prenatal testing (NIPT) has showed increased sensitivity and specificity for Down syndrome superior to any other screening test. Technical advances have made possible the detection of other conditions which does not necessarily mean clinical benefit for the patient. Private laboratories have added multiple conditions in the panel of NIPT, but some of these abnormalities are so rare, that their prevalence is not even clear. Data regarding clinical performance of extended NIPT is lacking. Implementation of such a test has to be carefully weighed, and not only the benefits but also the harm should be taken into account.

Keywords: Amniocentesis; NIPT; chromosomal abnormalities; genome.

PubMed Disclaimer

References

    1. Snijders R.J., et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998;352(9125):343–6. - PubMed
    1. Lo Y.M., et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–7. - PubMed
    1. Bianchi D.W., et al. Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology. Obstet Gynecol. 2015;125(2):375–82. - PubMed
    1. Wilson JMG, J.G., World Health Organization Principles and practice of screening for disease. 1968
    1. Chitty L.S., Hudgins L., Norton M.E. Current controversies in prenatal diagnosis 2: Cell-free DNA prenatal screening should be used to identify all chromosome abnormalities. Prenat Diagn. 2018;38(3):160–165. - PubMed

LinkOut - more resources